FIA NICHOLS: Open Payments
NPI 1972251353 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 13 payments from 8 companies in 2025. Trend: 2023 $115 · 2024 $38 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 3 | $60 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Veloxis Pharmaceuticals, Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Invivyd Inc | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Rezzayo, LIVTENCITY, PREVYMIS, ENVARSUS, VERQUVO, JARDIANCE, PEMGARDA, UPTRAVI.
Industry payments across NJ — which companies pay providers there.
